FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133066730> ?p ?o ?g. }

• W2133066730 endingPage "1491" @default.
• W2133066730 startingPage "1491" @default.
• W2133066730 abstract "AIM: To examine the growth inhibitory effects of Phyllanthus emblica (P. emblica) and Terminalia bellerica (T. bellerica) extracts on human hepatocellular carcinoma (HepG2), and lung carcinoma (A549) cells and their synergistic effect with doxorubicin or cisplatin. METHODS: HepG2 and A549 cells were treated with P. emblica and T. bellerica extracts either alone or in combination with doxorubicin or cisplatin and effects on cell growth were determined using the sulforhodamine B (SRB) assay. The isobologram and combination index (CI) method of Chou-Talalay were used to evaluate interactions between plant extracts and drugs. RESULTS: P. emblica and T. bellerica extracts demonstrated growth inhibitory activity, with a certain degree of selectivity against the two cancer cell lines tested. Synergistic effects (CI < 1) for P. emblica/doxorubicin or cisplatin at different dose levels were demonstrated in A549 and HepG2 cells. The T. bellerica/cisplatin or doxorubicin also showed synergistic effects in A549 and HepG2 cells. In some instances, the combinations resulted in antagonistic effects. The dose reduction level was different and specific to each combination and cell line. CONCLUSION: The growth inhibitory activity of doxorubicin or cisplatin, as a single agent, may be modified by combinations of P. emblica or T. bellerica extracts and be synergistically enhanced in some cases. Depending on the combination ratio, the doses for each drug for a given degree of effect in the combination may be reduced. The mechanisms involved in this interaction between chemotherapeutic drugs and plant extracts remain unclear and should be further evaluated. Key Words: Cisplatin, Doxorubicin, Liver cancer, Phyllanthus emblica, Synergistic effect, Terminalia bellerica Citation: Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol 2008; 14(10): 1491-1497 URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1491.htm DOI: https://dx.doi.org/10.3748/wjg.14.1491" @default.
• W2133066730 created "2016-06-24" @default.
• W2133066730 creator A5023237329 @default.
• W2133066730 creator A5035053129 @default.
• W2133066730 creator A5041543030 @default.
• W2133066730 creator A5041671553 @default.
• W2133066730 creator A5081977329 @default.
• W2133066730 date "2008-01-01" @default.
• W2133066730 modified "2023-10-17" @default.
• W2133066730 title "Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells" @default.
• W2133066730 cites W1508025216 @default.
• W2133066730 cites W1828224642 @default.
• W2133066730 cites W1971474452 @default.
• W2133066730 cites W1972800928 @default.
• W2133066730 cites W1973932751 @default.
• W2133066730 cites W1975717755 @default.
• W2133066730 cites W1980618862 @default.
• W2133066730 cites W1994331461 @default.
• W2133066730 cites W2009164637 @default.
• W2133066730 cites W2030205619 @default.
• W2133066730 cites W2035072754 @default.
• W2133066730 cites W2038876190 @default.
• W2133066730 cites W2045723173 @default.
• W2133066730 cites W2046598590 @default.
• W2133066730 cites W2047837951 @default.
• W2133066730 cites W2051340525 @default.
• W2133066730 cites W2058553205 @default.
• W2133066730 cites W2060932390 @default.
• W2133066730 cites W2061976838 @default.
• W2133066730 cites W2063658647 @default.
• W2133066730 cites W2077093369 @default.
• W2133066730 cites W2092392779 @default.
• W2133066730 cites W2097507831 @default.
• W2133066730 cites W2109689528 @default.
• W2133066730 cites W2113346253 @default.
• W2133066730 cites W2127013358 @default.
• W2133066730 cites W2141471714 @default.
• W2133066730 cites W2327068644 @default.
• W2133066730 cites W7559394 @default.
• W2133066730 doi "https://doi.org/10.3748/wjg.14.1491" @default.
• W2133066730 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2693740" @default.
• W2133066730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18330936" @default.
• W2133066730 hasPublicationYear "2008" @default.
• W2133066730 type Work @default.
• W2133066730 sameAs 2133066730 @default.
• W2133066730 citedByCount "85" @default.
• W2133066730 countsByYear W21330667302012 @default.
• W2133066730 countsByYear W21330667302013 @default.
• W2133066730 countsByYear W21330667302014 @default.
• W2133066730 countsByYear W21330667302015 @default.
• W2133066730 countsByYear W21330667302016 @default.
• W2133066730 countsByYear W21330667302017 @default.
• W2133066730 countsByYear W21330667302018 @default.
• W2133066730 countsByYear W21330667302019 @default.
• W2133066730 countsByYear W21330667302020 @default.
• W2133066730 countsByYear W21330667302021 @default.
• W2133066730 countsByYear W21330667302022 @default.
• W2133066730 countsByYear W21330667302023 @default.
• W2133066730 crossrefType "journal-article" @default.
• W2133066730 hasAuthorship W2133066730A5023237329 @default.
• W2133066730 hasAuthorship W2133066730A5035053129 @default.
• W2133066730 hasAuthorship W2133066730A5041543030 @default.
• W2133066730 hasAuthorship W2133066730A5041671553 @default.
• W2133066730 hasAuthorship W2133066730A5081977329 @default.
• W2133066730 hasBestOaLocation W21330667301 @default.
• W2133066730 hasConcept C109316439 @default.
• W2133066730 hasConcept C126322002 @default.
• W2133066730 hasConcept C143998085 @default.
• W2133066730 hasConcept C1491633281 @default.
• W2133066730 hasConcept C185592680 @default.
• W2133066730 hasConcept C202751555 @default.
• W2133066730 hasConcept C2776231280 @default.
• W2133066730 hasConcept C2776256026 @default.
• W2133066730 hasConcept C2776694085 @default.
• W2133066730 hasConcept C2778019345 @default.
• W2133066730 hasConcept C2778239845 @default.
• W2133066730 hasConcept C2781303535 @default.
• W2133066730 hasConcept C2910151965 @default.
• W2133066730 hasConcept C502942594 @default.
• W2133066730 hasConcept C55493867 @default.
• W2133066730 hasConcept C556039675 @default.
• W2133066730 hasConcept C71924100 @default.
• W2133066730 hasConcept C81729549 @default.
• W2133066730 hasConcept C98274493 @default.
• W2133066730 hasConceptScore W2133066730C109316439 @default.
• W2133066730 hasConceptScore W2133066730C126322002 @default.
• W2133066730 hasConceptScore W2133066730C143998085 @default.
• W2133066730 hasConceptScore W2133066730C1491633281 @default.
• W2133066730 hasConceptScore W2133066730C185592680 @default.
• W2133066730 hasConceptScore W2133066730C202751555 @default.
• W2133066730 hasConceptScore W2133066730C2776231280 @default.
• W2133066730 hasConceptScore W2133066730C2776256026 @default.
• W2133066730 hasConceptScore W2133066730C2776694085 @default.
• W2133066730 hasConceptScore W2133066730C2778019345 @default.
• W2133066730 hasConceptScore W2133066730C2778239845 @default.
• W2133066730 hasConceptScore W2133066730C2781303535 @default.
• W2133066730 hasConceptScore W2133066730C2910151965 @default.
• W2133066730 hasConceptScore W2133066730C502942594 @default.

• next